Genmab | Kortsiktig Gjeld

Current Liabilities Endring Dato
Almirall EUR 259.6M 91.48M 2024-03
Amarin USD 266.69M 4.24M 2023-09
Amgen USD 19.71B 1.32B 2024-03
AstraZeneca USD 28.59B 2.21B 2023-09
Bayer EUR 30.63B 1.17B 2024-03
BioMarin Pharmaceutical USD 1.09B 89.12M 2024-03
Demant DKK 9.26B 2.31B 2023-06
Exelixis USD 373.01M 3.81M 2024-03
Fresenius Medical Care EUR 6.2B 415.73M 2024-03
Galapagos EUR 382.21M 46.01M 2024-03
Genmab DKK 2.9B 909M 2023-09
GlaxoSmithKline GBP 19.85B 1.22B 2024-03
GN Store Nord DKK 14.57B 1.07B 2024-03
GRIFOLS EUR 2.32B 290.54M 2023-12
Hikma Pharmaceutical USD 1.22B 138M 2023-06
Insmed USD 420.86M 195.23M 2024-03
Lonza CHF 2.71B 369M 2023-06
Merck EUR 9.94B 1.25B 2024-03
Regeneron Pharmaceuticals USD 3.58B 823.3M 2024-03
Roche Holding CHF 26.21B 1.03B 2023-06
UCB EUR 2.65B 464M 2023-06



Genmab Kortsiktig Gjeld - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.